Please see Word document attached

Name
Instructor
Course
Date
Hemophilia, the Royal Pedigree, and Biotechnology DiscussionQuestion 1
Before the year 1978, scientists made insulin from pigs and cattle. However, the demand for insulin increased making it difficult to process enough insulin for everybody. The increase in demand for the drug, it was approximated that more than 8 million cows were needed on a yearly basis (Rother et al. 16). Cloning of insulin applies genetic technology to make synthetic human insulin in laboratories. This is through the use of a combination of DNA technologies that have been proven recently. However, because it cannot be enough, this morning has enabled scientists to make even more insulin to treat the diseases available. Because of the proofs available, we can trust products that are produced in bacteria or yeast for humans (Peacock-Young et al. 9). This is because it is the only way the people could not get enough insulin for the many diseases that require insulin for treatment. Santa’s usually coops the bacteria so that it can produce insulin after synthesizing the DNA at high concentration. Every bacteria is needed to churn out much protein per sell than they do under a microscope.
Question 2
Before cloning a clotting factor, it is best to test for the cloning factors that are available. As a result, there’s the need to use more blood samples. However, there are various risks for more blood samples such as acquired immunodeficiency virus, HIV and aids as well as hepatitis (Kwon et al.

15). As a result, this will require a clotting factor are exposed to these infections. It is, therefore, better to have cloning insulin rather than cloning a clotting factor that is exposed to diseases such as HIV. It is this reason why I feel that it is better to use cloning insulin. In these two cases, cloning insulin is cheaper because it is available in bacteria and yeast. In the past, people had been using clotting factor to transfer hemoglobin from those who had clotting factors to those who did not have. However, this proved to be a challenge as it exposed to people to diseases such as hepatitis and HIV.

Works cited
Kwon, Dae-Jin, et al. “Generation of α-1, 3-galactosyltransferase knocked-out transgenic cloned pigs with knocked-in five human genes.” Transgenic research 26.1 (2017): 153-163.
Peacock-Young, Barnaby, et al. “The prothrombotic state in paroxysmal nocturnal hemoglobinuria: a multifaceted source.” Haematologica 103.1 (2018): 9-17.
Rother, Russell P., et al. “The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease.” Jama 293.13 (2005): 1653-1662.